Minimally Invasive Surgical Technique in Periodontal Regeneration

20-minute MDS Viva Pedagogy

Learning objectives

1. Define minimally invasive periodontal surgery and differentiate MIS, MIST, and M-MIST.
2. Select appropriate intrabony defects and patients.
3. Describe the surgical steps of MIST and M-MIST.
4. Explain why wound stability and primary closure determine the outcome.
5. Critically discuss evidence, advantages, limitations, and regenerative materials.

0 to 2 minutes: Opening definition

Minimally invasive periodontal surgery refers to a regenerative surgical approach that uses limited incisions, minimal flap reflection, microsurgical instrumentation and magnification to obtain adequate access to an intrabony defect while preserving blood supply, soft tissue volume, papillary integrity, wound stability, and primary closure.

• Stable blood clot
• Primary wound closure
• Preserved vascularity
• Minimal tissue trauma
• Space maintenance where required
• Reduced bacterial contamination of the healing wound

2 to 5 minutes: Why minimally invasive surgery works

Biological rationale

• Flap displacement
• Clot instability
• Wound dehiscence
• Bacterial contamination
• Loss of blood supply
• Excessive surgical trauma
• Postoperative recession

Principle to say in viva

“The central principle of MIST is clot and wound stability. A stable fibrin clot acts as a scaffold for early wound healing and supports regenerative events at the root surface. Minimal flap elevation maintains tissue vascularity and reduces postoperative shrinkage and recession.”

How MIST supports healing

1. Limited incision and reflection
   • Reduced vascular disruption
   • Preserves papillary blood supply
   • Less edema, pain, and tissue shrinkage
2. Papilla preservation
   • Maintains soft-tissue bulk over the defect
   • Helps obtain primary closure
   • Particularly useful in anterior and esthetic areas
3. Microsurgery
   • Precise sharp dissection
   • Less tissue crushing
   • Fine sutures and precise approximation
   • Better early healing
4. Stable primary closure
   • Protects clot and regenerative material
   • Limits microbial contamination
   • Avoids membrane exposure if GTR is used

Important viva line

“Periodontal regeneration needs more than access and debridement. It requires a stable wound environment, which is the main contribution of minimally invasive flap design.”

5 to 7 minutes: Case selection

Ideal indication

• Isolated, deep, narrow intrabony defects
• Interdental defects, especially three-wall or contained two-wall defects
• Residual probing depth, generally at least 6 mm after initial therapy
• Sites with a radiographic intrabony component, usually 3 mm or more
• Adequate keratinized tissue and papillary volume
• Good oral hygiene and adherence to supportive periodontal care
• Teeth worth retaining strategically
• Esthetic-zone defects, where recession must be minimized

Defect morphology

Patient prerequisites

• Plaque and bleeding scores are low
• Smoking cessation or reduction counseling
• Diabetes and systemic conditions are controlled
• Cause-related periodontal therapy is complete
• Endodontic disease is addressed
• Occlusal trauma and mobility are evaluated
• The patient understands cost, healing requirements, and long-term maintenance

Contraindications or relative limitations

• Poor plaque control or unreliable maintenance attendance
• Uncontrolled diabetes or major systemic risk
• Heavy smoking
• Acute periodontal infection
• Very shallow, wide, non-contained defects where access and space maintenance are inadequate
• Severe tooth mobility that cannot be controlled
• Non-strategic tooth with poor restorative/endodontic prognosis
• Defects involving multiple surfaces where sufficient access cannot be obtained through a limited flap

7 to 12 minutes: Surgical procedure

A. MIST: surgical sequence

1. Pre-surgical phase

• Complete scaling and root planing.
• Re-evaluate pocket depth, CAL, bleeding, mobility, radiographic defect anatomy, and patient plaque control.
• Use preoperative radiograph, preferably standardized periapical imaging.
• Discuss the likelihood of regenerative versus merely clinical improvement.

2. Magnification and instruments

• Surgical microscope or loupes, approximately 4x to 16x magnification
• Microsurgical blades
• Microsurgical periosteal elevator
• Mini-curettes
• Fine needle holder and micro-forceps
• Fine monofilament sutures, commonly 6-0 or 7-0 depending on technique and operator preference

3. Incision and flap design

• Incision involves the defect-associated papilla and the adjacent buccal and lingual aspects.
• Incision choice is based on interdental space and papilla anatomy:
  • Modified papilla preservation technique for wider interdental spaces
  • Simplified papilla preservation flap for narrow spaces
• Elevate a limited full-thickness flap only enough to visualize the bone crest and defect.
• Avoid vertical releasing incisions where possible. If essential, keep them short, within attached gingiva, and do not extend across the mucogingival junction.

4. Debridement

• Remove granulation tissue sharply.
• Debride root surfaces thoroughly using mini-curettes and powered instruments if required.
• Irrigate frequently with sterile saline.
• Avoid unnecessary trauma to retained papillary connective tissue.

5. Apply regenerative material if indicated

• Enamel matrix derivative, EMD
• Bone graft or bone substitute
• GTR with a resorbable membrane
• Combination therapy, such as EMD plus graft
• rhPDGF-BB with beta-tricalcium phosphate, depending on indication and availability

• Defect containment
• Space-maintenance need
• Operator experience
• Risk of membrane exposure
• Patient-related and cost considerations

6. Suturing

• Reposition flaps passively at the original level.
• Obtain primary, tension-free closure.
• A single modified internal mattress suture at the defect-associated papilla is commonly used.
• Place additional simple sutures only when required.

B. M-MIST: modification and key difference

Definition

Core surgical feature

In M-MIST, only a small buccal triangular flap is elevated. The interdental papilla and palatal tissues are left intact.

Steps

1. Make a tiny buccal incision at the defect-associated papilla.
2. Elevate only a small buccal triangular flap.
3. Leave the papilla attached to the root surface through supracrestal fibers.
4. Remove granulation tissue through the buccal window using microblades and mini-curettes.
5. Thoroughly debride and condition the root as indicated.
6. Place EMD, graft, or other regenerative material if planned.
7. Achieve primary closure with a single internal modified mattress suture.

Why M-MIST may be advantageous

• Papilla remains intact and “hangs” over the interdental defect.
• Better blood supply is retained.
• Minimal flap elevation reduces trauma.
• The intact papilla improves clot stability and space maintenance.
• The undisturbed palatal tissue supports the wound.
• Lower morbidity and less recession are expected.

When M-MIST is unsuitable

• There is a substantial lingual/palatal intrabony component
• Adequate access and debridement cannot be achieved through a buccal window
• The defect is extensive, circumferential, or involves multiple adjacent spaces
• The anatomy makes the papilla too thin or unstable

12 to 14 minutes: Postoperative care

Immediate postoperative care

• Gentle pressure for hemostasis
• Analgesics according to patient need and medical history
• Chlorhexidine rinse may be used when brushing is temporarily restricted
• Do not mechanically clean the surgical site initially
• Soft diet and avoid trauma to the area
• No smoking
• Review at 1 week for wound evaluation and suture removal according to healing and material used

Maintenance phase

• Meticulous plaque control
• Professional supportive periodontal care
• Gradual resumption of atraumatic brushing
• Monitor PD, CAL, bleeding on probing, recession, mobility, and radiographic bone fill

Expected healing

• Early primary closure is the target.
• Clinical reevaluation is usually at 6 to 12 months.
• Clinical success means reduced PD, CAL gain, stable gingival margin, absence of bleeding/suppuration, and maintainability.

14 to 17 minutes: Evidence and critical appraisal

Foundational clinical results

1. Cortellini and Tonetti, 2009

• 20 patients were enrolled.
• M-MIST was applied in 15 defects.
• At 1 year: mean CAL gain 4.5 ± 1.4 mm.
• Residual PD: 3.1 ± 0.6 mm.
• Mean gingival recession increase: 0.1 ± 0.3 mm.
• Primary closure was maintained in all treated M-MIST sites, with no edema or hematoma and no reported pain/discomfort.

2. Ribeiro et al., 2011 RCT

• Both groups had significant PD reduction and CAL gain.
• No significant difference was found between groups at 3 or 6 months.

3. Windisch et al., 2022 two-center RCT

• CAL gain: 4.09 ± 1.68 mm with minimally invasive flap versus 3.79 ± 1.67 mm with extended flap.
• PD reduction: 4.52 ± 1.34 mm versus 4.04 ± 1.62 mm.
• No statistically significant difference in final clinical outcomes.
• Early wound healing favored the minimally invasive group.

4. Liu et al., 2022 RCT

• Both groups achieved significant CAL gain.
• No statistically significant difference at 1 year.
• Better early wound healing was observed with MIST alone.

5. Aimetti et al., 2024 RCT

• CAL gain: 3.9 ± 1.1 mm with EMD versus 3.0 ± 1.2 mm without EMD.
• Radiographic bone fill: 3.0 ± 1.0 mm versus 1.8 ± 1.5 mm.
• Composite success was higher with EMD: 82.6% versus 52.2%.

6. Recent systematic review and meta-analysis

• Nine studies were included.
• Significant PD reduction and CAL gain were generally reported.
• Gingival recession increase was non-significant.
• Study heterogeneity was moderate to substantial for CAL/PD in some analyses.
• The authors concluded that minimally invasive and papilla-preserving procedures can improve intrabony defect outcomes with low morbidity.

“The evidence supports MIST and M-MIST as effective low-morbidity approaches, but heterogeneity in defect anatomy, biomaterials, surgical experience, and study design prevents claiming superiority over all conventional papilla-preservation approaches.” Pasqualini et al.

17 to 18 minutes: Advantages, limitations, and complications

Advantages

• Less tissue trauma
• Reduced postoperative edema, pain, and morbidity
• Better papillary preservation
• Less gingival recession, especially relevant in esthetic areas
• Better clot stability and primary closure
• Reduced surgical time in selected isolated defects
• Improved patient acceptance
• Precise surgery with magnification and microsurgical instruments

Limitations

• Technique-sensitive
• Requires microsurgical training and magnification
• Limited access can compromise debridement in complex defects
• Cannot be applied to all defect morphologies
• Need for excellent patient plaque control and maintenance
• No uniform protocol for incision design, adjunctive materials, or outcome assessment
• Clinical improvement is not automatically histologic proof of regeneration
• Materials may add cost without predictable additional benefit in every well-contained defect

Potential complications

• Incomplete debridement due to limited access
• Flap tear or papillary perforation
• Failure to obtain passive primary closure
• Wound dehiscence
• Membrane exposure, if GTR is used
• Postoperative recession
• Persistent deep pocket
• Failure to maintain regenerative gain due to plaque accumulation or poor maintenance

Rapid viva questions with model answers

1. What is the difference between MIST and M-MIST?

2. What is the most important determinant of success in MIST?

3. Why is M-MIST called self-supporting?

4. What are the ideal defects for M-MIST?

5. When would you prefer conventional MIST over M-MIST?

6. Is EMD mandatory in MIST?

7. Why not use a membrane in all MIST cases?

8. Can radiographic bone fill be called periodontal regeneration?

9. What is the role of magnification?

10. What is your final clinical message?

Suggested final 30-second viva conclusion

“Minimally invasive periodontal regenerative surgery is a wound-stability-centered approach. MIST provides limited access through papilla-preserving incisions, while M-MIST further preserves the interdental papilla by raising only a buccal flap. These procedures can provide substantial CAL gain, PD reduction, less recession, and low morbidity in well-selected intrabony defects. However, they are technique-sensitive and should not compromise adequate debridement or appropriate material selection.”

Important references

1. Newman MG, Takei HH, Klokkevold PR, Carranza FA, eds. Newman and Carranza’s Clinical Periodontology and Implantology. 14th ed. Chapter 63, Periodontal Regeneration.
   • Conservative/minimally invasive flap principles, MIST, M-MIST, SFA, EMD and rhPDGF observations: lines 110523-110543 of the supplied text.
2. Lindhe J, Lang NP, Karring T, eds. Clinical Periodontology and Implant Dentistry. 6th ed. Chapter 45, Reconstructive Therapy.
   • MIST surgical procedure, M-MIST design, clinical outcomes, complications, and patient morbidity: supplied text pp. 927-938, lines 91471-92393.
3. Cortellini P, Tonetti MS. Improved wound stability with a modified minimally invasive surgical technique in the regenerative treatment of isolated interdental intrabony defects. J Clin Periodontol. 2009;36:157-163. DOI: 10.1111/j.1600-051X.2008.01352.x. PubMed record
4. Ribeiro FV, Casarin RCV, Nociti FH Jr, Sallum EA, Casati MZ. The role of enamel matrix derivative protein in minimally invasive surgery in treating intrabony defects in single-rooted teeth: a randomized clinical trial. J Periodontol. 2011;82:522-532. DOI: 10.1902/jop.2010.100454. PubMed record
5. Cortellini P, Nieri M, Prato GPP, Tonetti MS. Single minimally invasive surgical technique with enamel matrix derivative to treat multiple adjacent intrabony defects: clinical outcomes and patient morbidity. J Clin Periodontol. 2008;35:605-613. DOI: 10.1111/j.1600-051X.2008.01242.x. PubMed record
6. Windisch P, Iorio-Siciliano V, Palkovics D, et al. The role of surgical flap design on healing of intrabony defects treated with enamel matrix derivative: a 12-month two-center randomized controlled clinical trial. Clin Oral Investig. 2022;26:2361-2373. DOI: 10.1007/s00784-021-04155-5. PubMed record
7. Liu B, Ouyang X, Kang J, et al. Efficacy of periodontal minimally invasive surgery with and without regenerative materials for treatment of intrabony defect: a randomized clinical trial. Clin Oral Investig. 2022;26:1757-1766. DOI: 10.1007/s00784-021-04134-w. PubMed record
8. Aimetti M, Stasikelyte M, Mariani GM, et al. The flapless approach with and without enamel matrix derivatives for treatment of intrabony defects: a randomized controlled clinical trial. J Clin Periodontol. 2024;51:1412-1423. DOI: 10.1111/jcpe.14028. PubMed record
9. Pasqualini E, Castro F, Curado D, et al. Minimally invasive periodontal regeneration with the buccal approach: a systematic review and meta-analysis of clinical studies. Evid Based Dent. 2024. DOI: 10.1038/s41432-023-00964-7. PubMed record
10. Reynolds MA, Kao RT, Camargo PM, et al. Periodontal regeneration - intrabony defects: a consensus report from the AAP Regeneration Workshop. J Periodontol. 2015;86:S105-S107. DOI: 10.1902/jop.2015.140378. PubMed record